Valuation: NeuroPace, Inc.

Market Cap 507M 438M 411M 374M 703M 48.47B 713M 4.81B 1.89B 24.28B 1.9B 1.86B 80.78B P/E 2026 *
-29.3x
P/E 2027 * -54.8x
Enterprise Value 530M 458M 429M 391M 735M 50.69B 746M 5.03B 1.97B 25.4B 1.99B 1.95B 84.48B EV / Sales 2026 *
5.29x
EV / Sales 2027 * 4.26x
Free-Float
83.08%
Yield 2026 *
-
Yield 2027 * -
1 day-3.28%
1 week-3.60%
Current month+11.29%
1 month-10.79%
3 months-10.29%
6 months-7.33%
Current year-7.09%
1 week 14.16
Extreme 14.16
15.38
1 month 12.66
Extreme 12.66
16.35
Current year 12.47
Extreme 12.47
19.6
1 year 8.17
Extreme 8.17
19.6
3 years 4.29
Extreme 4.29
19.6
5 years 1.22
Extreme 1.22
24.65
10 years 1.22
Extreme 1.22
27.38
Manager TitleAgeSince
Chief Executive Officer 58 2023-07-09
Director of Finance/CFO 53 2025-06-19
Chief Tech/Sci/R&D Officer - 2024-09-03
Director TitleAgeSince
Director/Board Member 57 2012-12-31
Chairman 84 1997-11-30
Director/Board Member 46 2021-03-31
Date Insider Type Main position Quantity % Market Cap.
6/19/26 Free

Director

789 0.0023%
5/15/26 Free

Chief Financial Officer

61,620 0.1815%
2/27/26 Tax

Chief Executive Officer

1,126 0.0034%
Change 5-day change 1-year change 3-year change Capi.($)
-3.32%-3.60%+70.37%+224.55% 507M
-0.21%-2.11%+20.40%+9.53% 218B
-0.18%-3.61%-3.44%-20.17% 142B
-0.98%-0.78%-18.90%+34.55% 139B
-0.33%+2.30%-49.91%+1.33% 75.11B
-0.82%-1.28%+16.03%+18.25% 52.8B
-0.79%-0.43%-17.43%-15.38% 50.66B
+0.22%+0.01%+25.89%+23.08% 41.95B
-1.17%-1.09%+40.73%+49.10% 40.49B
-1.97%-0.86%-1.18%+5.73% 33.28B
Average -0.98%+1.41%+8.26%+33.06% 79.4B
Weighted average by Cap. -0.55%+1.12%+0.33%+9.52%

Financials

2026 *2027 *
Net sales 100M 86.52M 81.17M 73.93M 139M 9.58B 141M 952M 373M 4.8B 376M 368M 15.97B 123M 106M 99.37M 90.51M 170M 11.73B 173M 1.16B 456M 5.88B 461M 451M 19.55B
Net income -17.35M -14.98M -14.05M -12.8M -24.06M -1.66B -24.4M -165M -64.55M -831M -65.13M -63.72M -2.76B -9.63M -8.32M -7.8M -7.11M -13.36M -921M -13.55M -91.47M -35.84M -462M -36.17M -35.39M -1.54B
Net Debt 23.21M 20.04M 18.8M 17.12M 32.2M 2.22B 32.64M 220M 86.36M 1.11B 87.15M 85.26M 3.7B 16.02M 13.83M 12.97M 11.82M 22.22M 1.53B 22.53M 152M 59.6M 767M 60.14M 58.84M 2.55B
Logo NeuroPace, Inc.
NeuroPace, Inc. is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company's RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders. The Company's RNS System includes its RNS neurostimulator, its cortical strip leads and depth leads, and its Patient Remote Monitor, as well as other implantable and non-implantable accessories. The Company's product offerings also include Physician Tablet, Patient Data Management System (PDMS) and nSight Platform, which facilitate ongoing patient monitoring and streamline patient support. The PDMS is an online database.
Employees
220
Date Price Change Volume
26-08-17 US$14.35 -2.88% 90,065
26-08-14 US$14.77 +1.79% 154,960
26-08-13 US$14.51 -0.34% 112,791
26-08-12 US$14.56 -3.26% 186,273
26-08-11 US$15.05 +1.14% 248,341
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
14.77USD
Average target price
20.22USD
Spread / Average Target
+36.91%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NPCE Stock